Latest BRCA2 Stories
A novel therapy designed to attack tumors in patients with a genetic mutation in either BRCA1 or BRCA2, slowed tumor growth in 85 percent of advanced breast cancer patients treated in a small study.
LANSDALE, Pa., May 13 /PRNewswire/ -- A guide to BRCA1 and BRCA2 genetic testing has been released by Hayes, Inc.
Westchester Medical Center Physician and Fertility Preservation Expert leads study examining the association of breast cancer genes, breast cancer and infertility VALHALLA, N.Y., Dec.
Women with mutations in either their BRCA1 or BRCA2 genes have a dramatically increased risk of developing breast or ovarian cancer.
SALT LAKE CITY, Sept. 14 /PRNewswire-FirstCall/ -- Myriad Genetics, Inc. (Nasdaq: MYGN) announced today that it has launched a hereditary breast and ovarian cancer Public Awareness Campaign in five Midwest states, including Illinois, Indiana, Kentucky, Missouri and Ohio.
Exercise lowered breast cancer risk 52 percent of women entering or past menopause, Canadian researchers said. The study, published in the Journal of Cancer Epidemiology, reinforced the correlation between breast cancer and being overweight or a smoker. The study looked at 280 women with breast cancer and 280 women without cancer.
A recent study published in the Journal of Cancer Epidemiology has reinforced the correlation between being overweight, smoking and breast cancer. What makes this study unique is how test subjects were not diagnosed for BRCA1 and BRCA2 gene mutations, which predispose women to breast cancer.
Forty percent of women who have a high risk of breast cancer had risk-reducing mastectomies and 45 percent had ovaries removed, British researchers said. These surgeries are widely used by carriers of BRCA1 and BRCA2 gene mutations to reduce the risk for breast and ovarian cancer.
Many women at high risk for breast or ovarian cancer are choosing to undergo surgery as a precautionary measure to decrease their cancer risk, according to a report in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.
Patenting pure genes linked to diseases is unconstitutional and slows down research progress, civil liberties advocates claim. American Civil Liberties Union Executive Director Anthony Romero says constitutional rights to knowledge about the human body and to make pertinent healthcare decisions are at stake when private companies are allowed to hold patents on genes found responsible for diseases, CNN reported Wednesday. The ACLU and Yeshiva University's law school filed suit in U.S.
- A serpent whose bite was fabled to produce intense thirst.